COVID-19 pandemic
Preliminary tests indicate that the Oxford–AstraZeneca COVID-19 vaccine may reduce transmission of COVID-19 and not simply prevent symptomatic infections.
Sources: U.S. News & World Report via MSN
Changes
- Preliminary tests indicate that the Oxford–AstraZeneca COVID-19 vaccine may reduce transmission of COVID-19, and not simply prevent symptomatic infections.
- Preliminary tests indicate that the Oxford–AstraZeneca COVID-19 vaccine may reduce transmission of COVID-19 and not simply prevent symptomatic infections.
Related
South Sudan President Salva Kiir Mayardit receives his first dose of the AstraZenaca vaccine.
Cambodia approves the emergency use of the Oxford-AstraZeneca and Sinovac Biotech vaccines.
Bahrain approves the Oxford–AstraZeneca vaccine for emergency use in the country.